His primary scientific interests are in Internal medicine, Cancer research, Endocrinology, Breast cancer and Cancer. His work on Oncology expands to the thematically related Internal medicine. His Cancer research research includes elements of Cancer cell, Apoptosis, Cell cycle, Insulin-like growth factor 1 receptor and Growth factor receptor.
His Endocrinology study incorporates themes from Growth factor, Signal transduction, Tyrosine phosphorylation and Estrogen receptor. The concepts of his Breast cancer study are interwoven with issues in Point mutation, Randomized controlled trial, Surgery and In vivo. Douglas Yee has researched Cancer in several fields, including Diabetes mellitus and Clinical trial.
Douglas Yee focuses on Internal medicine, Breast cancer, Cancer research, Cancer and Endocrinology. Internal medicine is closely attributed to Oncology in his work. His research in Breast cancer intersects with topics in Immunology, Clinical trial and Chemotherapy.
His studies deal with areas such as Insulin receptor, Insulin-like growth factor 1 receptor, Growth factor and Signal transduction, Growth factor receptor as well as Cancer research. His research on Cancer frequently links to adjacent areas such as Bioinformatics. His Endocrinology research incorporates elements of Cell culture, Autocrine signalling, Cell growth, Cancer cell and Insulin-like growth factor-binding protein.
Douglas Yee mainly focuses on Internal medicine, Breast cancer, Oncology, Cancer and Cancer research. His study ties his expertise on Endocrinology together with the subject of Internal medicine. The study incorporates disciplines such as Stage, Complete response, Clinical trial and Randomized controlled trial in addition to Breast cancer.
His Oncology research focuses on Neoadjuvant therapy and how it connects with Surgery. His study looks at the relationship between Cancer and topics such as Cyclophosphamide, which overlap with Paclitaxel. His Cancer research research integrates issues from Insulin receptor, Cancer cell, Receptor, Metastasis and Estrogen receptor.
Douglas Yee mainly investigates Internal medicine, Breast cancer, Oncology, Cancer and Clinical trial. His Internal medicine study combines topics in areas such as Endocrinology and Cardiology. His study in Endocrinology is interdisciplinary in nature, drawing from both Cancer cell, PDK4 and Mutation.
His studies in Breast cancer integrate themes in fields like Stage, Randomized controlled trial and Receiver operating characteristic. His work on Breast cancer screening as part of general Cancer research is frequently linked to Multimedia, Intervention and Health care, thereby connecting diverse disciplines of science. Douglas Yee interconnects Cancer research, Downregulation and upregulation, Insulin-like growth factor 1 receptor, Growth factor and Signal transduction in the investigation of issues within Insulin receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diabetes and Cancer: A consensus report
Edward L. Giovannucci;David M. Harlan;Michael C. Archer;Richard M. Bergenstal.
Diabetes Care (2010)
APOBEC3B is an enzymatic source of mutation in breast cancer
Michael B. Burns;Lela Lackey;Michael A. Carpenter;Anurag Rathore.
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins.
Marta Guix;Anthony C. Faber;Shizhen Emily Wang;Maria Graciela Olivares.
Journal of Clinical Investigation (2008)
Morphine Stimulates Angiogenesis by Activating Proangiogenic and Survival-promoting Signaling and Promotes Breast Tumor Growth
Kalpna Gupta;Smita Kshirsagar;Liming Chang;Robert Schwartz.
Cancer Research (2002)
Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer
Douglas Yee;Soonmyoung Paik;Soonmyoung Paik;Gail S. Lebovic;Gail S. Lebovic;Rachel R. Marcus;Rachel R. Marcus.
Molecular Endocrinology (1989)
Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
Hope S. Rugo;Olufunmilayo I. Olopade;Angela DeMichele;Christina Yau.
The New England Journal of Medicine (2016)
Randomized Controlled Trial of Weight Training and Lymphedema in Breast Cancer Survivors
Rehana L. Ahmed;William Thomas;Douglas Yee;Kathryn H. Schmitz.
Journal of Clinical Oncology (2006)
Insulin-like Growth Factor Receptor Expression and Function in Human Breast Cancer
Kevin J. Cullen;Douglas Yee;William S. Sly;James Perdue.
Cancer Research (1990)
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
A. V. Lee;J. G. Jackson;J. L. Gooch;S. G. Hilsenbeck.
Molecular Endocrinology (1999)
The IGF system and breast cancer.
Deepali Sachdev;Douglas Yee.
Endocrine-related Cancer (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: